We are live on ! Find out more

3,435 hedge funds and large institutions have $216B invested in Merck in 2023 Q4 according to their latest regulatory filings, with 378 funds opening new positions, 1,245 increasing their positions, 1,486 reducing their positions, and 107 closing their positions.

New
Increased
Maintained
Reduced
Closed

253% more first-time investments, than exits

New positions opened: 378 | Existing positions closed: 107

10% more call options, than puts

Call options by funds: $1.92B | Put options by funds: $1.75B

9% more capital invested

Capital invested by funds: $199B → $216B (+$17.4B)

7% more funds holding

Funds holding: 3,2143,435 (+221)

2.47% more ownership

Funds ownership: 75.65%78.12% (+2.5%)

5% less funds holding in top 10

Funds holding in top 10: 186177 (-9)

16% less repeat investments, than reductions

Existing positions increased: 1,245 | Existing positions reduced: 1,486

Holders
3,435
Holders Change
+221
Holders Change %
+6.88%
% of All Funds
50.07%
Holding in Top 10
177
Holding in Top 10 Change
-9
Holding in Top 10 Change %
-4.84%
% of All Funds
2.58%
New
378
Increased
1,245
Reduced
1,486
Closed
107
Calls
$1.92B
Puts
$1.75B
Net Calls
+$175M
Net Calls Change
-$230M
Name Holding Trade Value Shares
Change
Change in
Stake
AWM
1051
Avitas Wealth Management
California
$5.06M +$153K +1,477 +3%
CCG
1052
Cypress Capital Group
Florida
$5.05M -$36.6K -353 -0.8%
JFL
1053
Jarislowsky, Fraser Ltd
Quebec, Canada
$5.04M -$42.9K -413 -0.9%
LIM
1054
Leavell Investment Management
Alabama
$5.02M +$285K +2,749 +6%
HAI
1055
Hennessy Advisors Inc
California
$5M -$270K -2,600 -5%
JWM
1056
Jackson Wealth Management
Florida
$5M -$33.8K -326 -0.7%
AA
1057
Ancora Advisors
Ohio
$4.99M +$160K +1,537 +3%
RWM
1058
Rockline Wealth Management
New York
$4.99M +$4.75M +45,777 New
B
1059
Bailard
California
$4.97M -$218K -2,102 -4%
FCMT
1060
Founders Capital Management (Texas)
Texas
$4.96M -$26.6K -256 -0.6%
CT
1061
Chicago Trust
Illinois
$4.96M -$179K -1,725 -4%
PWP
1062
Perfromance Wealth Partners
Illinois
$4.95M -$237K -2,281 -5%
Verition Fund Management
1063
Verition Fund Management
Connecticut
$4.95M -$4.94M -47,597 -51%
RP
1064
Rowlandmiller & Partners
Georgia
$4.94M -$56.6K -545 -1%
AR
1065
Advisory Research
Illinois
$4.92M -$3.32M -32,009 -42%
GIM
1066
Greylin Investment Management
Virginia
$4.89M -$106K -1,025 -2%
RC
1067
Roundview Capital
New Jersey
$4.88M +$85.8K +827 +2%
SAIG
1068
Semper Augustus Investments Group
Colorado
$4.86M +$13.6K +131 +0.3%
CHAM
1069
Clear Harbor Asset Management
Connecticut
$4.85M -$21.3K -205 -0.5%
HVP
1070
Hudson Value Partners
Florida
$4.85M +$186K +1,794 +4%
CCG
1071
Chatham Capital Group
Georgia
$4.85M +$14K +135 +0.3%
BCM
1072
Birmingham Capital Management
Alabama
$4.84M -$226K -2,175 -5%
FWM
1073
Finer Wealth Management
Massachusetts
$4.82M -$71.7K -691 -2%
SSI
1074
Scott & Selber Inc
Texas
$4.82M -$48.1K -463 -1%
EWM
1075
Executive Wealth Management
Michigan
$4.82M +$4.17M +40,135 +984%

MRK Hedge Fund Activity: Q4 2023 in Review

3,435 of the 6,860 institutional investors tracked by Wall St. Rank reported a position in Merck (MRK) for Q4 2023, worth a combined $216B — up 8.8% from $199B a quarter earlier.

Buyers outnumbered sellers: 378 funds opened new MRK positions and 107 closed out — a net gain of 271 holders — while 1,245 added to existing stakes and 1,486 trimmed.

The largest buyer was Morgan Stanley, adding an estimated $4.32B. The largest seller was Bank of New York Mellon, cutting an estimated $432M.

  • 3,435 institutional investors held Merck (MRK) as of Q4 2023, up from 3,214 in Q3 2023.
  • Funds reported $216B of Merck stock for Q4 2023, up 8.8% quarter-over-quarter.
  • 378 funds opened new Merck positions in Q4 2023 and 107 closed out, a net change of +271 holders.
  • The largest Merck buyer in Q4 2023 was Morgan Stanley, an estimated $4.32B added.
  • The largest Merck seller in Q4 2023 was Bank of New York Mellon, an estimated $432M sold.

Based on aggregated 13F filings for Q4 2023.